A California biotech company expects to begin trials of a treatment for spinal cord injuries next year.
Studying how gene expression differs in identical twins could shed light on how genes and environment interact.
Protein profiles are uncovering weak spots in cancer's armor.
Oil-eating bacteria offer new hope for bioremediation.
New drugs that target the brain's nicotine receptors, without the addictiveness of cigarettes, might help memory impairment in Alzheimer's disease and schizophrenia.
The Pentagon is committing $51 million to creating a tool for acoustic cauterization.
Scientists plan to use the biofermentation of genetically engineered microorganisms to produce large batches of fruit fragrances.
A study of long-lived families will help isolate the genetic mysteries that allow some people to live disease-free into their nineties and beyond.
A design with holes in it could replace polymer-coated stents, which have been linked to heart attacks.
New brain-imaging techniques could teach people to strengthen the parts of the brain that control attention.